PB 66 of 2014
National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 7)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 6 August 2014
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 7).
(2) This Determination may also be cited as PB 66 of 2014.
2 Commencement
This Determination commences on the day after it is registered.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Epoetin Lambda
Omit
Epoprostenol
[2] Schedule 2, after item dealing with Epirubicin
Insert
Epoprostenol
